Valneva SE VALN
NASDAQ VALN
$6.89 -0.17 (-2.41%)
At close: Sep 4, 2026 · 4:00 PM EDT

Valneva SE (VALN) Cash & Current Investments (2019 - 2026)

Valneva SE (VALN) posted Cash & Current Investments of $123.2 million for Q1 2026, down 3.45% sequentially from $127.6 million in Q4 2025, and down 23.42% YoY from $160.9 million in Q1 2025.

Analysis

Valneva SE (VALN) Cash & Current Investments (2019 - 2026) Analysis & Trends

Valneva SE has reported Cash & Current Investments for 8 years, with the latest figure at $123.2 million in Q1 2026.

  • Quarterly Cash & Current Investments fell 23.42% year-over-year to $123.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $123.2 million (down 23.42% YoY) and the FY2025 annual result came in at $127.6 million, down 30.44% from the prior year.
  • Cash & Current Investments declined to $123.2 million in Q1 2026 per VALN's latest filing, from $127.6 million in the prior quarter.
  • Over five years, Cash & Current Investments peaked at $358.8 million in Q2 2022 and troughed at $123.2 million in Q1 2026.
  • A 5-year average of $207.7 million and a median of $184.1 million in 2025 frame the typical range for Cash & Current Investments.
  • The sharpest annual moves came in 2022 and 2023: Cash & Current Investments surged 638756.95% in 2022, then tumbled 53.6% in 2023.
  • Over 5 years, Cash & Current Investments stood at $292.3 million in 2022, then sank by 53.6% to $135.7 million in 2023, then soared by 33.54% to $181.2 million in 2024, then decreased by 29.54% to $127.6 million in 2025, then dropped by 3.45% to $123.2 million in 2026.
  • According to Business Quant data, Cash & Current Investments over the past three periods registered $123.2 million, $127.6 million, and $167.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 5.14 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 5.10 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 3.31 Bn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 836.99 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.16 Bn
10 Valneva SE 578.54 Mn 437.28 Mn 1.86 Mn 141.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 141.26 Mn
Mar 31, 2026 123.24 Mn
Dec 31, 2025 127.64 Mn
Sep 30, 2025 167.71 Mn
Jun 30, 2025 233.39 Mn
Mar 31, 2025 160.93 Mn
Dec 31, 2024 231.81 Mn
Sep 30, 2024 171.69 Mn
Jun 30, 2024 141.52 Mn
Mar 31, 2024 191.89 Mn
Dec 31, 2023 198.07 Mn
Sep 30, 2023 186.42 Mn
Jun 30, 2023 288.83 Mn
Mar 31, 2023 273.15 Mn
Dec 31, 2022 364.15 Mn
Sep 30, 2022 263.20 Mn
Jun 30, 2022 358.77 Mn
Mar 31, 2022 349.34 Mn
Dec 31, 2021 45,758.84
Sep 30, 2021 292.40 Mn